| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Clearline Capital LP | 5.5% | $628,870 | 635,222 | Clearline Capital LP | 31 Dec 2024 |
As of 30 Sep 2025, 43 institutional investors reported holding 3,303,788 shares of TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD). This represents 29% of the company’s total 11,549,491 outstanding shares.
The largest institutional shareholders of TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) together control 29% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 10% | 1,192,191 | 0% | 0.02% | $1,281,605 |
| Clearline Capital LP | 5.5% | 635,222 | 0% | 0.06% | $682,864 |
| VANGUARD GROUP INC | 3.3% | 376,828 | -0.57% | 0% | $399,437 |
| Tejara Capital Ltd | 3% | 344,203 | -0.01% | 0.2% | $370,018 |
| ADAR1 Capital Management, LLC | 1.8% | 209,210 | 0% | 0.02% | $224,901 |
| MORGAN STANLEY | 1.1% | 130,572 | -0.49% | 0% | $140,365 |
| BlackRock, Inc. | 1% | 116,132 | 0% | 0% | $124,842 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.94% | 109,083 | 0% | 0% | $115,656 |
| RENAISSANCE TECHNOLOGIES LLC | 0.31% | 35,500 | +138% | 0% | $38,163 |
| CITADEL ADVISORS LLC | 0.3% | 34,273 | 0% | $36,329 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.29% | 34,000 | 0% | 0% | $36,040 |
| STATE STREET CORP | 0.26% | 30,100 | 0% | 0% | $31,906 |
| NORTHERN TRUST CORP | 0.14% | 16,457 | 0% | 0% | $17,691 |
| J. Goldman & Co LP | 0.12% | 13,562 | 0% | 0% | $14,579 |
| TWO SIGMA SECURITIES, LLC | 0.1% | 11,967 | +15% | 0% | $12,865 |
| FMR LLC | 0.07% | 8,289 | 0% | 0% | $8,786 |
| Tower Research Capital LLC (TRC) | 0.02% | 2,733 | -5.2% | 0% | $2,938 |
| OSAIC HOLDINGS, INC. | 0.01% | 897 | +4.2% | 0% | $972 |
| NATIONAL BANK OF CANADA /FI/ | 0.01% | 670 | -5.6% | 0% | $710 |
| UBS Group AG | 0% | 362 | -92% | 0% | $390 |
| JPMORGAN CHASE & CO | 0% | 293 | 0% | 0% | $310 |
| SBI Securities Co., Ltd. | 0% | 255 | 0% | 0% | $274 |
| US BANCORP \DE\ | 0% | 246 | 0% | 0% | $264 |
| BNP PARIBAS FINANCIAL MARKETS | 0% | 226 | 0% | 0% | $243 |
| HUNTINGTON NATIONAL BANK | 0% | 120 | 0% | 0% | $129 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 3,303,788 | $3,542,705 | +$51,253 | $1.08 | 43 |
| 2025 Q2 | 3,255,627 | $3,776,528 | -$96,760 | $1.16 | 39 |
| 2025 Q1 | 3,343,589 | $3,092,849 | -$161,729 | $0.92 | 39 |
| 2024 Q4 | 3,528,705 | $3,034,744 | +$127,775 | $0.86 | 36 |
| 2024 Q3 | 3,379,006 | $5,609,190 | -$32,659 | $1.66 | 34 |
| 2024 Q2 | 3,408,546 | $5,487,847 | -$143 | $1.61 | 33 |
| 2024 Q1 | 3,377,023 | $7,732,743 | +$286,706 | $2.29 | 41 |
| 2023 Q4 | 3,251,847 | $7,316,509 | -$53,338 | $2.25 | 34 |
| 2023 Q3 | 2,987,535 | $9,022,675 | -$189,949 | $3.02 | 37 |
| 2023 Q2 | 3,030,126 | $12,484,021 | -$298,990 | $4.12 | 39 |
| 2023 Q1 | 3,114,675 | $11,680,289 | -$1,635,929 | $3.75 | 39 |
| 2022 Q4 | 3,475,432 | $19,427,979 | +$6,039,049 | $5.59 | 43 |
| 2022 Q3 | 2,068,834 | $13,736,198 | +$169,055 | $6.64 | 26 |
| 2022 Q2 | 1,716,457 | $17,078,726 | +$17,070,675 | $9.95 | 31 |
| 2022 Q1 | 10,800 | $4,104 | +$304 | $0.38 | 2 |
| 2021 Q4 | 10,000 | $3,555 | $0 | $0.36 | 1 |